日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intranasal replicon vaccine establishes mucosal immunity and protects against H5N1 and H7N9 influenza.

鼻内复制子疫苗可建立粘膜免疫,并能预防 H5N1 和 H7N9 流感。

Ykema Matthew R, Davis Michael A, Kasal Darshan N, Jennewein Madeleine F, Lo Ethan, Singh Jasneet, Beaver Samuel, Cross Noah, Melief Eduard, Reed Sierra, Press Christopher, Brandt Devin S, McClary Wynton D, Mohamath Raodoh, Fusco Pauline, Bakken Julie, Casper Corey, Hartwig Airn Tolnay, Gerhardt Alana, Bowen Richard A, Voigt Emily A

A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses.

一种针对黄热病和寨卡病毒的二价自扩增RNA疫苗

Battisti Peter, Ykema Matthew R, Kasal Darshan N, Jennewein Madeleine F, Beaver Samuel, Weight Abbie E, Hanson Derek, Singh Jasneet, Bakken Julie, Cross Noah, Fusco Pauline, Archer Jacob, Reed Sierra, Gerhardt Alana, Julander Justin G, Casper Corey, Voigt Emily A

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.

优化 SARS-CoV-2 亚单位疫苗组合物的免疫原性和产品呈现:给药途径、异源方案与自扩增 RNA 疫苗和冻干的影响

Lykins William R, Pollet Jeroen, White Jessica A, Keegan Brian, Versteeg Leroy, Strych Ulrich, Chen Wen-Hsiang, Mohamath Raodoh, Ramer-Denisoff Gabi, Reed Sierra, Renshaw Christina, Beaver Samuel, Gerhardt Alana, Voigt Emily A, Tomai Mark A, Sitrin Robert, Choy Robert K M, Cassels Frederick J, Hotez Peter J, Bottazzi Maria Elena, Fox Christopher B

Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccine.

佐剂和抗原组成的选择会改变 SARS-CoV-2 亚单位疫苗的免疫原性

Lykins William R, Pollet Jeroen, White Jessica A, Keegan Brian, Versteeg Leroy, Strych Ulrich, Chen Wen-Hsiang, Mohamath Raodoh, Ramer-Denisoff Gabi, Reed Sierra, Beaver Samuel, Gerhardt Alana, Voigt Emily A, Tomai Mark A, Sitrin Robert, Choy Robert K M, Cassels Frederick J, Hotez Peter J, Bottazzi Maria Elena, Fox Christopher B